Fort Lee, NJ, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…
CHATHAM, N.J., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products…
NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…
Phase 1/2 clinical trial initiated evaluating Immatics’ second next-generation half-life extended TCR Bispecific program, TCER® IMA402 targeting PRAMEACTengine® IMA203 TCR-T…
-- FY 2023 Adjusted non-GAAP EBITDA expected to be $78.0 - $84.0 million1 ---- FY 2023 Adjusted non-GAAP earnings per…
- 402 patients completed enrollment across multiple sites in the US, Europe, and Asia – - Topline data for Phase…
Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants Reference is made to the press release of…
BBS-Bioactive Bone Substitutes Plc, Company announcement, 17 August 2023 at 12:00 p.m. Conversion of convertible notes pursuant to financing arrangement…
Jaguar Health family company Napo Pharmaceuticals focuses on essential supportive care and management of neglected toxicities in multiple complicated disease…
The pharmaceutical technology company secures number 867 on the list of America’s fastest-growing privately owned companiesORLANDO, Fla., Aug. 16, 2023…